| Cardiovascular Risk Management |
1 |
1 |
| Lipids Management |
0 |
0.59 |
| Hypertension |
0 |
0.56 |
| Metabolism |
0 |
0.49 |
| Atrial Fibrillation |
0 |
0.44 |
| Blood |
0 |
0.4 |
| Blood-Brain Barrier |
0 |
0.4 |
| Pain Management |
0 |
0.33 |
| Toxicology |
0 |
0.31 |
| Psychotropic Drugs |
0 |
0.3 |
| Receptors |
0 |
0.3 |
| Depression |
0 |
0.28 |
| Arrhythmia |
0 |
0.25 |
| LDL Cholesterol |
0 |
0.24 |
| Anxiety Disorder |
0 |
0.21 |
| Headache |
0 |
0.21 |
| Weight Management |
0 |
0.21 |
| Anxiety |
0 |
0.2 |
| Brain |
0 |
0.2 |
| Fatigue |
0 |
0.2 |
| Tolerance |
0 |
0.2 |
| Weight Loss |
0 |
0.2 |
| Addiction |
0 |
0.16 |
| Type 2 Diabetes Mellitus |
0 |
0.16 |
| Aminotransferase |
0 |
0.14 |
| Adverse Effects |
0 |
0.1 |
| Antidepressant drug |
0 |
0.1 |
| Artificial Intelligence |
0 |
0.1 |
| Bronchodilator |
0 |
0.1 |
| Cardiovascular disease |
0 |
0.1 |
| Child |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.1 |
| Heart |
0 |
0.1 |
| Influenza |
0 |
0.1 |
| Italy |
0 |
0.1 |
| Lipoproteins |
0 |
0.1 |
| Liver |
0 |
0.1 |
| Meta-Analysis |
0 |
0.1 |
| Newborn |
0 |
0.1 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.1 |
| Overdose |
0 |
0.1 |
| Pain |
0 |
0.1 |
| Palpitations |
0 |
0.1 |
| Patient History |
0 |
0.1 |
| Patient Safety |
0 |
0.1 |
| Pregnancy |
0 |
0.1 |
| Sleep |
0 |
0.1 |
| Triglycerides |
0 |
0.1 |